Keyphrases
Erdheim-Chester Disease
100%
Disease Case
100%
Interferon-α (IFN-α)
33%
Bone Biopsy
33%
Arab
16%
Second-line Treatment
16%
Imaging Studies
16%
Bisphosphonates
16%
Neuroimaging
16%
Immunohistochemistry
16%
Clinical Evaluation
16%
Medical History
16%
Clinical Manifestations
16%
Clinical Presentation
16%
Anakinra
16%
Radiation Therapy
16%
Clinical Course
16%
Pathognomonic
16%
Multiple Organs
16%
Diagnostic Evaluation
16%
Infliximab
16%
Multisystem
16%
Multiple Tissues
16%
Laboratory Evaluation
16%
Overproduction
16%
White Blood Cells
16%
Cladribine
16%
Pathological Features
16%
Diabetes Insipidus
16%
Pathological Findings
16%
Hyperprolactinemia
16%
Histiocytes
16%
Bone Pain
16%
Langerhans Cell Histiocytosis
16%
Osteosclerosis
16%
Vemurafenib
16%
Infiltrative Disease
16%
Non-Langerhans-Cell
16%
Jakob Erdheim
16%
Rheumatologic
16%
BRAF Inhibitor (BRAFi)
16%
Possible Treatments
16%
Diabetes Secondary
16%
Secondary Hypogonadism
16%
Medicine and Dentistry
Erdheim-Chester Disease
100%
Disease
33%
Histiocytosis
33%
Bone Biopsy
33%
Interferon
33%
Diagnosis
16%
Bisphosphonate
16%
Clinical Trial
16%
Leukocyte
16%
Immunohistochemistry
16%
Medical History
16%
Anakinra
16%
Disease Course
16%
Radiation Therapy
16%
Pathognomonic
16%
Diabetes Insipidus
16%
Bone Pain
16%
Hyperprolactinemia
16%
Hypogonadism
16%
Osteosclerosis
16%
Vemurafenib
16%
Infiltrative Disease
16%
Cladribine
16%
Infliximab
16%
Histiocyte
16%
Langerhans Cell
16%